Flulaval, 2025/2026 - Influenza virus vaccine, 2025/2026 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL Suspension 0.5 mL
Reference details for licensed healthcare facility review and verification.
| NDC 11 | 19515-0904-52 |
|---|---|
| Product NDC | 19515-0904 |
| Generic Drug Name | influenza virus vaccine, 2025/2026 |
| Brand Name | Flulaval, 2025/2026 |
| Manufacturer | ID Biomedical Corporation of Quebec |
| Strength | 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL |
| Dosage Form | Suspension |
| Drug Type | Intramuscular |
| Package Quantity | 10 Syringe |
| Package Description | 10 SYRINGE in 1 CARTON (19515-904-52) / .5 mL in 1 SYRINGE (19515-904-41) |
| Active Ingredients | Influenza A Virus A/Croatia/10136Rv/2023 X-425A (H3N2) Antigen (Uv, Formaldehyde Inactivated); Influenza A Virus A/Victoria/4897/2022 Ivr-238 (H1N1) Antigen (Uv, Formaldehyde Inactivated); Influenza B Virus B/Austria/1359417/2021 Bvr-26 Antigen (Uv, Formaldehyde Inactivated) |
| Marketing Category | BLA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
influenza virus vaccine, 2025/2026 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL Suspension is tracked under NDC 19515-0904-52 and rolls up into product family 19515-0904. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.
- Package configuration: 10 Syringe.
- Manufacturer: ID Biomedical Corporation of Quebec.
- Dosage form: Suspension.
- Family size: 1 indexed presentation.
Click a tag to refine the catalog view around this product reference.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Potential alternatives with matching presentation
Open the comparison hub or review package-level listings from 2 product-NDC families with matching normalized presentation details. Review each product detail page before treating any item as a true alternative.
Flulaval, 2025/2026 - Influenza virus vaccine, 2025/2026 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL Suspension 0.5 mL, NDC 19515-0904-52, is a ID Biomedical Corporation of Quebec 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL suspension presentation packaged as 10 Syringe.
NDC search formats
- Canonical NDC 11: 19515-0904-52
- Digits-only NDC 11: 19515090452
- Possible 10-digit display format: 19515-904-52 (1951590452)
Helpful product links
- Search by brand name: Flulaval, 2025/2026
- NDC 11: 19515-0904-52
- Product family NDC: 19515-0904
- VA classification code: IM100
- VA classification code description: VACCINES
- CMOP ID: I0549
- VUID: 4032582